Woodline Partners’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.98M | Buy |
301,197
+119
| +0% | +$3.15K | 0.04% | 471 |
|
|
2025
Q1 | $7.27M | Buy |
301,078
+207,784
| +223% | +$5.02M | 0.05% | 415 |
|
|
2024
Q4 | $3.75M | Buy |
93,294
+29,475
| +46% | +$1.19M | 0.03% | 545 |
|
|
2024
Q3 | $4.04M | Sell |
63,819
-1,607
| -2% | -$102K | 0.03% | 413 |
|
|
2024
Q2 | $3.47M | Buy |
65,426
+118
| +0.2% | +$6.26K | 0.03% | 373 |
|
|
2024
Q1 | $5.36M | Buy |
+65,308
| New | +$5.36M | 0.05% | 349 |
|